FilingSEC EDGAR8-K
Turn Therapeutics to present at Stifel 2026 Virtual Immunology and Inflammation Forum
· SEC accepted
StageClinical Presentation
Filing content
Turn Therapeutics (TTRX) announced that it will present its atopic dermatitis clinical program at the Stifel 2026 Virtual Immunology and Inflammation Forum.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…